act

Advanced Cell Technology pub: Trial for Macular Degeneration

ACT-FIgure-1-

The stem cell biotech Advanced Cell Technology (ACT) reported new, positive data in a paper in Lancet from their clinical trials using retinal pigmented epithelial cells (RPEs) made from human embryonic stem cells (hESC) for treatment of different forms of macular degeneration (MD). The paper was entitled “Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related …

Advanced Cell Technology pub: Trial for Macular Degeneration Read More »

Key questions for stem cell field bouncing around on a Friday morning

ViaCyte-New-Logo

What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at the moment in no particular order. You can see a lot of translational/clinical things are on my mind. I’ve …

Key questions for stem cell field bouncing around on a Friday morning Read More »

Interview with Bob Lanza on new ACT MSCs for MS paper

I did a brief email Q&A interview with Dr. Bob Lanza of Advanced Cell Technology (ACT) on their new hES MSCs pre-clinical data for Multiple Sclerosis. I discussed the paper itself in a concise review yesterday here. Thanks to Dr. Lanza for doing the interview. 1. Were you surprised at the fact that the therapeutic …

Interview with Bob Lanza on new ACT MSCs for MS paper Read More »

Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS

advanced-cell-technology

There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of …

Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »

Review of New ACT Paper on hESC-derived MSCs

advanced-cell-technology-150x1501

Advanced Cell Technology (ACT; $ACTC) has a new paper out on using human embryonic stem cells (hESC) to make MSCs with potentially powerful therapeutic potential. The paper, entitled Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties, was published in the journal Stem Cells and Development. What’s the scoop on this …

Review of New ACT Paper on hESC-derived MSCs Read More »

Big Changes Unfolding at Advanced Cell Technology (ACTC)

advanced-cell-technology

Stem cell biotech, Advanced Cell Technology (ACT; stock symbol ACTC), has started off 2014 with indications that it is in a phase of rapid evolution. Some changes, such as today’s announced departure of now former CEO Gary Rabin (see my 2013 interview with him here), are already in the public domain, but other big developments …

Big Changes Unfolding at Advanced Cell Technology (ACTC) Read More »

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis

dancing-mice

Is Advanced Cell Technology (ACT) on the road to cure Multiple Sclerosis (MS) using stem cells and specifically MSCs? Some folks seem to think it’s quite possible, but I remain skeptical. Still there have been some interesting developments. ACT has a relatively new patent filing for a mesenchymal stromal cell (MSC) product that was just …

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis Read More »